American Oncology Institute (AOI) the leading cancer care provider in South Asia has been awarded the 2020 Frost & Sullivan Award for its Competitive Strategy Innovation and Leadership.
Hyderabad, October 30, 2020 – Globally renowned consulting firm, Frost & Sullivan, has awarded American Oncology Institute for its Competitive Strategy, Innovation and Leadership at the recently held 2020 India Best Practices Awards Ceremony.
AOI, a focussed Cancer Care chain has grown from a network of 3 hospitals to 16 hospitals over the last 26 months. With presence ranging from the North East to Jammu to Sri Lanka, the Cancer care chain caters to a population base of 300 Mn and has maintained its leadership in differentiation due to its quality clinical protocols, superior technology, evidence-based practice to identify and prevent cancer at the earliest stage possible, benchmarked clinical outcomes and superior service standards. With affordability, access and best-in-class care at the forefront, AOI is leading the fight against cancer in South Asia. AOI’s growth trajectory, industry leading financial performance and differentiated approach to healthcare delivery have driven this recognition.
The vision of the organization is to build an evidence-based practice to meet the highest standards for trust, transparency, and technology while taking care of patient needs. It also provides patients with expert care by leveraging an International Tumor Board wherein clinicians from across Oncology Hospitals in the developed countries participate with AOI’s hospitals to jointly review complex cases.
The strategy of American Oncology Institute constitutes a holistic care model to support the needs of the patients. AOI’s hospitals are designed to offer a spectrum of treatment services including medical oncology, surgical oncology, radiation oncology, haematology-oncology, and high-end oncology diagnostics (like PETCT, SPECT, CT, real time tumour tracking). Moreover, the company offers advanced diagnostic services such as histopathology, molecular pathology, cytogenetics, and next-generation sequencing. The company’s robust IT infrastructure ensures seamless data processing across the treatment cycle.
Dr. Jagprag Singh Gujral, Group CEO- South Asia, CTSI (Cancer Treatment Services International) has dedicated this award to the commitment of 2500 employees across the network and said “Team AOI thanks its patients for entrusting us as your care providers; its partners and caregivers for subscribing to its Vision; and all its team members for being the pillars behind this recognition”
This Press Release has not been vetted or endorsed by The Eastern Herald’s editorial staff.